Paper36980536
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.
Andreu-Sanz D and 1 other. Cancers (Basel), 2023. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy. Papers, record 36980536. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980536
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References172
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20969597 | Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20969597 | PubMed |
| 2 | 32457487 | Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/32457487 | PubMed |
| 3 | 1403061 | Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1403061 | PubMed |
| 4 | 18599325 | Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. | Immunity | 2008 | https://conductscience.org/library/papers/18599325 | PubMed |
| 5 | 12121660 | IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. | Immunity | 2002 | https://conductscience.org/library/papers/12121660 | PubMed |
| 6 | 9529155 | Defective NK cell activity and Th1 response in IL-18-deficient mice. | Immunity | 1998 | https://conductscience.org/library/papers/9529155 | PubMed |
| 7 | 34678512 | IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors. | Mol Ther | 2022 | https://conductscience.org/library/papers/34678512 | PubMed |
| 8 | 24108699 | Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement. | J Immunol | 2013 | https://conductscience.org/library/papers/24108699 | PubMed |
| 9 | 23807677 | Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23807677 | PubMed |
| 10 | 31142602 | Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma. | J Immunol | 2019 | https://conductscience.org/library/papers/31142602 | PubMed |
| 11 | 23021777 | A validated regulatory network for Th17 cell specification. | Cell | 2012 | https://conductscience.org/library/papers/23021777 | PubMed |
| 12 | 26875830 | Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26875830 | PubMed |
| 13 | 32041222 | Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32041222 | PubMed |
| 14 | 34995901 | IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy. | Biomaterials | 2022 | https://conductscience.org/library/papers/34995901 | PubMed |
| 15 | 18924115 | Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. | Hematol Oncol | 2009 | https://conductscience.org/library/papers/18924115 | PubMed |
| 16 | 27589682 | TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27589682 | PubMed |
| 17 | 10438927 | IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. | J Immunol | 1999 | https://conductscience.org/library/papers/10438927 | PubMed |
| 18 | 29894691 | Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29894691 | PubMed |
| 19 | 30914642 | IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling. | Nat Commun | 2019 | https://conductscience.org/library/papers/30914642 | PubMed |
| 20 | 9551990 | Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors. | J Immunol | 1998 | https://conductscience.org/library/papers/9551990 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935572 | Influencing the exposome, patient macroenvironment, tumor microenvironment through-line to improve clinical outcomes. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935572 | PubMed |
| 42889415 | Systemic immune activation coexists with compartment-specific regulatory enrichment in matched blood, peritumor, and tumor tissue from advanced oral squamous cell carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889415 | PubMed |
| 42889049 | Neutrophils suppress adaptive αβ T cells but not the innate γδ T cells and natural killer cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889049 | PubMed |
| 42506281 | Purinergic and Energy Metabolism Disruption in Oxidative Stress-Mediated Immunotoxicity Induced by Aflatoxin B1 and Fumonisin B1. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506281 | PubMed |
| 42309580 | Computational design and molecular characterization of a multi-epitope peptide vaccine targeting pancreatic cancer. | J Genet Eng Biotechnol | 2026 | https://conductscience.org/library/papers/42309580 | PubMed |
| 42298533 | Bioinformatics mining and clinical validation of CD274 as a prognostic indicator in hepatocellular carcinoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42298533 | PubMed |
| 42253973 | Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial. | Front Immunol | 2026 | https://conductscience.org/library/papers/42253973 | PubMed |
| 42183154 | Nanoparticle induction of antigen-presenting monocyte-derived dendritic cells relieves immunosuppression and inhibits metastasis. | Cell Biomater | 2026 | https://conductscience.org/library/papers/42183154 | PubMed |
| 42148142 | The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148142 | PubMed |
| 42074260 | Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074260 | PubMed |
| 41884334 | A Single-Cell Atlas of Pan-Cancer Liver Metastasis Reveals Dynamic Cellular Programs Driving Metastatic Progression and Immune Modulation. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/41884334 | PubMed |
| 41825936 | Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41825936 | PubMed |
| 41757567 | Tumor microenvironment and key signaling pathways in breast cancer progression and therapy resistance: A review. | Biomol Biomed | 2026 | https://conductscience.org/library/papers/41757567 | PubMed |
| 41622714 | Integrative Analysis of Multiomic Pathways Predicts Cancer-Affected Lobes in Lung Cancer. | Cancer Prev Res (Phila) | 2026 | https://conductscience.org/library/papers/41622714 | PubMed |
| 41441899 | Commensal bacteria antigen-mediated immune response enhances anti-tumor immunity. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/41441899 | PubMed |
| 41407509 | Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer. | J Gene Med | 2025 | https://conductscience.org/library/papers/41407509 | PubMed |
| 41244711 | Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/41244711 | PubMed |
| 41228276 | Integrated Multi-Omics Analysis Identifies SRI as a Critical Target Promoting Gastric Cancer Progression and Associated with Poor Prognosis. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228276 | PubMed |
| 40725022 | Tumor Microenvironment in Melanoma-Characteristic and Clinical Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725022 | PubMed |
| 40594069 | Pan-cancer analysis reveals ASCC family promotes the cancer progression of lung adenocarcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594069 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980536
GET https://conductscience.org/api/papers/v1/36980536/references?page=2